Concourse Financial Group Securities, Inc. Uni Qure N.V. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$3.78 - $10.12 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$4.39 - $5.43 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	SELL	$4.82 - $6.93 $4,709 - $6,770	-977 Closed	0 $0
Q4 2023 Feb 07, 2024	SELL	$5.63 - $8.27 $4,425 - $6,500	-786 Reduced 44.58%	977 $6,000
Q3 2023 Oct 25, 2023	BUY	$6.71 - $11.83 $2,744 - $4,838	409 Added 30.21%	1,763 $11,000
Q2 2023 Aug 10, 2023	SELL	$11.12 - $22.2 $1,167 - $2,331	-105 Reduced 7.2%	1,354 $15,000
Q1 2023 May 15, 2023	SELL	$18.7 - $23.07 $3,179 - $3,921	-170 Reduced 10.44%	1,459 $29,000
Q4 2022 Jan 30, 2023	BUY	$18.12 - $27.32 $29,517 - $44,504	1,629 New	1,629 $0
Q3 2022 Nov 15, 2022	SELL	$16.98 - $25.54 $39,529 - $59,457	-2,328 Closed	0 $0
Q2 2022 Aug 09, 2022	SELL	$13.15 - $20.45 $3,931 - $6,114	-299 Reduced 11.38%	2,328 $43,000
Q1 2022 May 09, 2022	BUY	$14.54 - $21.5 $5,350 - $7,912	368 Added 16.29%	2,627 $47,000
Q4 2021 Feb 07, 2022	SELL	$20.24 - $36.01 $1,173 - $2,088	-58 Reduced 2.5%	2,259 $47,000
Q3 2021 Nov 09, 2021	SELL	$26.01 - $38.22 $3,251 - $4,777	-125 Reduced 5.12%	2,317 $74,000
Q2 2021 Aug 13, 2021	SELL	$29.97 - $37.17 $19,060 - $23,640	-636 Reduced 20.66%	2,442 $75,000
Q1 2021 May 13, 2021	BUY	$29.24 - $42.03 $27,953 - $40,180	956 Added 45.05%	3,078 $104,000
Q4 2020 Feb 02, 2021	BUY	$35.35 - $50.67 $23,543 - $33,746	666 Added 45.74%	2,122 $77,000
Q3 2020 Nov 13, 2020	BUY	$35.98 - $47.66 $9,030 - $11,962	251 Added 20.83%	1,456 $54,000
Q2 2020 Aug 13, 2020	BUY	$45.06 - $67.74 $6,083 - $9,144	135 Added 12.62%	1,205 $54,000
Q1 2020 May 13, 2020	SELL	$40.01 - $73.97 $40 - $73	-1 Reduced 0.09%	1,070 $51,000
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $14,777 - $29,698	398 Added 59.14%	1,071 $77,000
Q3 2019 Nov 13, 2019	BUY	$39.36 - $76.8 $14,523 - $28,339	369 Added 121.38%	673 $26,000
Q2 2019 Aug 13, 2019	BUY	$52.76 - $82.19 $11,818 - $18,410	224 Added 280.0%	304 $24,000
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $2,191 - $5,472	80 New	80 $4,000
Q4 2018 Feb 14, 2019	BUY	$22.8 - $33.93 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$29.75 - $43.08 $0 - $0	0 New	0 $0

Others Institutions Holding QURE

# of Institutions

153

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

Vestal Point Capital, LP New York, NY

4.75M
Shares

$27.5 Million
1.78% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.78M
Shares

$16.1 Million
0.81% of portfolio
Boxer Capital, LLC San Diego, CA

2.23M
Shares

$12.9 Million
0.58% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.19M
Shares

$12.7 Million
0.01% of portfolio
Abrdn PLC

1.93M
Shares

$11.1 Million
0.02% of portfolio

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $270M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account